ATE1145T1 - 3-Alkylxanthines, processes for their preparation and compositions for use in the treatment of chronic obstructive airway disease and cardiac disease.

40 members in 25 offices

This recordMember, by publication datePriority claim15 more offices are in the list below

Priority claims
Document	Office	Kind	Date
7810947	Sweden	A	1978-10-20

Family members, oldest first
Document	Office	Kind
PT70350A	Portugal	A	1979-11-01
IE791987L	Ireland	L	1980-04-20
DK432179A	Denmark	A	1980-04-21
FI793224A	Finland	A	1980-04-21
FI793224A7	Finland	A7	1980-04-21
SE7810947L	Sweden	L	1980-04-21
NO793377L	Norway	L	1980-04-22
JPS5557589A	Japan	A	1980-04-28
EP0010531A1	European Patent Office (EPO)	A1	1980-04-30
AU5187179A	Australia	A	1980-05-01
ES485178A1	Spain	A1	1980-05-16
PL219065A1	Poland	A1	1980-06-16
ZA795113B	South Africa	B	1980-10-29
DD146708A5	German Democratic Republic (until 1990)	A5	1981-02-25
PL119413B1	Poland	B1	1981-12-31
EP0010531B1	European Patent Office (EPO)	B1	1982-06-02
AT1145T	Austria	T	1982-06-15
ATE1145T1This record	Austria	T1	1982-06-15
DE2963021D1	Germany	D1	1982-07-22
SU952105A3	Soviet Union (until 1991)	A3	1982-08-15
CA1131632A	Canada	A	1982-09-14
HU180220B	Hungary	B	1983-02-28
CA1142928A	Canada	A	1983-03-15
AU530717B2	Australia	B2	1983-07-28
PH16676A	Philippines	A	1983-12-13
GR72945B	Greece	B	1984-01-17
NZ191870A	New Zealand	A	1984-07-06
FI66867B	Finland	B	1984-08-31
FI66867C	Finland	C	1984-12-10
HK7785A	Hong Kong, China	A	1985-02-08
SG86084G	Singapore	G	1985-06-07
NO152561B	Norway	B	1985-07-08
IE49184B1	Ireland	B1	1985-08-21
NO152561C	Norway	C	1985-10-16
US4548818A	United States of America	A	1985-10-22
DK148884B	Denmark	B	1985-11-04
MY110285A	Malaysia	A	1985-12-31
DK148884C	Denmark	C	1986-04-07
US4644001A	United States of America	A	1987-02-17
JPH0130834B2	Japan	B2	1989-06-22

2 legal events, as the office reported them to INPADOC

Point at a mark for the event

Legal events, newest first
	Event	Code
1987-06-15	Ceased due to non-payment of the annual feeCeasedREN	REN
1982-08-15	Publication of translation of european patent specificationUEP	UEP

German: 3-ALKYLXANTHINE, VERFAHREN ZU IHRER HERSTELLUNG UND ZUSAMMENSETZUNGEN ZUR BENUTZUNG IN DER BEHANDLUNG CHRONISCH VERLEGTER ATEMWEGE UND VON HERZKRANKHEITEN.
English: 3-ALKYLXANTHINE, METHODS FOR THEIR PREPARATION AND COMPOSITIONS FOR USE IN THE TREATMENT OF CHRONIC AIRWAY OBSTRUCTION AND HEART DISEASES.

CPC, 5: C07D239/545
C07D473/06
A61P11/08
A61P9/00
A61P9/04
Filled: the office’s first classification
IPC, 9: C07D473 04
A61K31 52
A61K31 522
A61P9 00
A61P9 04
A61P11 08
C07D239 54
C07D239 545
C07D473 06

3-Alkylxanthines, processes for their preparation and compositions for use in the treatment of chronic obstructive airway disease and cardiac disease.